SCHEMBL5496444

SCHEMBL5496444

COc1ccc(CC(=O)O)cc1.COc1ccc(CC(=O)O)cc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.54
PTGS1 P23219 1/20 0.54
AKR1C3 P42330 1/20 0.54
AKR1C2 P52895 1/20 0.54
ALDH1A1 P00352 7/20 0.53
NPC1 O15118 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
RAB9A P51151 2/20 0.52
LMNA P02545 3/20 0.51
HTT P42858 2/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
HSD17B10 Q99714 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
KDM4E B2RXH2 1/20 0.50
POLB P06746 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5496450 1.00 GAA (0.54) GAAPTGS1AKR1C3AKR1C2ALDH1A1
SCHEMBL2976618 0.93 GAA (0.60) GAAALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL2976612 0.93 GAA (0.60) GAAALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL5496448 0.88 ALDH1A1 (0.52) GAAALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL5256348 0.87 GAA (0.57) GAAALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL6293793 0.82 ALDH1A1 (0.62) GAAALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL5673785 0.82 ALDH1A1 (0.60) GAAPTGS1AKR1C3AKR1C2ALDH1A1
SCHEMBL2593397 0.82 ALDH1A1 (0.60) GAAPTGS1AKR1C3AKR1C2ALDH1A1
SCHEMBL5256345 0.82 ALDH1A1 (0.53) GAAALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL2742576 0.81 ALDH1A1 (0.62) GAAALDH1A1SMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC. (US) 2007-09-26 EP disclosed
WO-2006039718-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2006-04-13 WO disclosed